This Order prohibits, subject to exceptions, the retail sale, and the supply in circumstances corresponding to retail sale, of medicinal products that consist of or contain a list of gonadotrophin-releasing hormone (“GnRH”) analogues (article 4). It is the fourth such Order – and is made in effectively the same terms as the temporary Order which preceded it, the Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) (No. 2) Order 2024 (S.I. 2024/1110), which expires immediately before this Order comes into force.